Skip to content
DPH - Public Health

Hepatitis/HIV/Syphilis 4th Gen Assay Screening IFB

Solicitation: Not available
Notice ID: 24-482DPH-OFCDI-B-41682

Federal opportunity from OFCDISCONTRL482 - Office of Disease Control • DPH - Public Health. Place of performance: IL. Response deadline: May 06, 2024.

Market snapshot

Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).

12-month awarded value
$659,327,406
Sector total $659,327,406 • Share 100.0%
Live
Median
$157,798
P10–P90
$29,611$1,830,899
Volatility
Volatile200%
Market composition
NAICS share of sector
A simple concentration signal, not a forecast.
100.0%
share
Momentum (last 3 vs prior 3 buckets)
+100%($659,327,406)
Deal sizing
$157,798 median
Use as a pricing centerline.
Live signal is computed from awarded notices already observed in the system.
Signals shown are descriptive of observed awards; not a forecast.

Related hubs & trends

Navigate the lattice: hubs for browsing, trends for pricing signals.

We write these bids →
Open on official portal →
Map for IL
Live POP
Place of performance
Chris Vogt 1155 S Oakland Carbondale, IL 62901 US Email: chris.vogt@illinois.gov Phone: (618) 457-5131
State: IL
Contracting office
Not listed

Point of Contact

Not available

Agency & Office

Department
DPH - Public Health
Agency
OFCDISCONTRL482 - Office of Disease Control
Subagency
OFCDISCONTRL482 - Office of Disease Control
Office
DA001 - Office of Disease Control
Contracting Office Address
Not available

Description

Hepatitis/HIV/Syphilis 4th Gen Assay Screening IFB IDPH Laboratory Invitation For Bid of HIV 4th generation HIV-1/HIV-2 antibodies, p24 antigen, Syphilis IgG and IgM antibody testing, and Hepatitis B and C testing. Item # 1: ( 193 - 40 ) Year One - Hepatitis B surface antigen (HBsAg), Hepatitis B surface antibody (Anti-HBs), and total antibody (IgM and IgG) to Hepatitis B core antigen (Total anti-HBc). The cost per test result, inclusive of all reagents (test kits, controls, & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 3,300 screening tests per year (includes 3,000 serum specimens, 10% repeat testing and daily controls). All shipping charges will be covered by Vendor. Year One - Hepatitis B surface antigen (HBsAg), Hepatitis B surface antibody (Anti-HBs), and total antibody (IgM and IgG) to Hepatitis B core antigen (Total anti-HBc). The cost per test result, inclusive of all reagents (test kits, controls, & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 3,300 screening tests per year (includes 3,000 serum specimens, 10% repeat testing and daily controls). All shipping charges will be covered by Vendor. Item # 2: ( 193 - 40 ) Year One - Hepatitis C antibody (anti-HCV). This includes approximately 3,000 screening tests per year (includes 2,700 serum specimens, 10% repeat testing and daily controls). The cost per test result, inclusive of all reagents (test kits, controls, & calibrators), consumables, and instrumentation necessary to perform qualitative detection. IDPH Division of Labs reserves the right to implement this testing during the term of the contract. All shipping charges will be covered by Vendor. Year One - Hepatitis C antibody (anti-HCV). This includes approximately 3,000 screening tests per year (includes 2,700 serum specimens, 10% repeat testing and daily controls). The cost per test result, inclusive of all reagents (test kits, controls, & calibrators), consumables, and instrumentation necessary to perform qualitative detection. IDPH Division of Labs reserves the right to implement this testing during the term of the contract. All shipping charges will be covered by Vendor. Item # 3: ( 193 - 40 ) Year One - HIV-1 and HIV-2 antibodies and p24 antigen to the Human Immunodeficiency Virus (HIV) using 4th generation chemiluminescent technology. The cost per test result, inclusive of all reagents (test kits, controls & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 13,200 screening tests per year (includes 12,000 serum specimens, 10% repeat testing and daily controls). All shipping charges will be covered by Vendor. Year One - HIV-1 and HIV-2 antibodies and p24 antigen to the Human Immunodeficiency Virus (HIV) using 4th generation chemiluminescent technology. The cost per test result, inclusive of all reagents (test kits, controls & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 13,200 screening tests per year (includes 12,000 serum specimens, 10% repeat testing and daily controls). All shipping charges will be covered by Vendor. Item # 4: ( 193 - 40 ) Year One - Syphilis (Treponema Pallidum) IgG and IgM antibodies. The cost per test result, inclusive of all reagents (test kits, controls & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 11,000 screening tests per year (includes 10,000 serum specimens, 10% repeat testing and daily controls. All shipping charges will be covered by Vendor. Year One - Syphilis (Treponema Pallidum) IgG and IgM antibodies. The cost per test result, inclusive of all reagents (test kits, controls & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 11,000 screening tests per year (includes 10,000 serum specimens, 10% repeat testing and daily controls. All shipping charges will be covered by Vendor. Item # 5: ( 193 - 40 ) Year Two - Hepatitis B surface antigen (HBsAg), Hepatitis B surface antibody (Anti-HBs), and total antibody (IgM and IgG) to Hepatitis B core antigen (Total anti-HBc). The cost per test result, inclusive of all reagents (test kits, controls, & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 3,300 screening tests per year (includes 3,000 serum specimens, 10% repeat testing and daily controls). All delivery charges will be covered by Vendor. Year Two - Hepatitis B surface antigen (HBsAg), Hepatitis B surface antibody (Anti-HBs), and total antibody (IgM and IgG) to Hepatitis B core antigen (Total anti-HBc). The cost per test result, inclusive of all reagents (test kits, controls, & calibrators), consumables, and instrumentation necessary to perform qualitative detection. This includes approximately 3,300 screening tests per year (includes 3,000 serum specimens, 10% repeat testing and daily controls). All delivery charges will be covered by Vendor.

Files

Files size/type shown when available.

BidPulsar Analysis

A practical, capture-style breakdown of fit, requirements, risks, and next steps.

Analysis is being generated for this notice. Check back shortly.

FAQ

How do I use the Market Snapshot?

It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.

Is the data live?

The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.

What do P10 and P90 mean?

P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.